Health Technology Assessments for the Swiss Medical Board

Barbier, Michaela C et al. (2022) ‘Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer.’, PloS one, 17(11), p. e0277282. Available at: https://doi.org/10.1371/journal.pone.0277282.

Menges, Dominik et al. (2022) ‘Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment.’, European urology oncology, 5(6), pp. 605–616. Available at: https://doi.org/10.1016/j.euo.2022.04.007.